Treatment of ocular myasthenia -: Steroids only when compelled

被引：35

作者：

Kaminski, HJ ^{[1
]}

Daroff, RB ^{[1
]}

机构：

[1] Case Western Reserve Univ, Dept Neurol, Dept Vet Affairs Med Ctr Cleveland, Univ Hosp Cleveland,Sch Med, Cleveland, OH 44106 USA

来源：

ARCHIVES OF NEUROLOGY | 2000年 / 57卷 / 05期

关键词：

D O I：

10.1001/archneur.57.5.752

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：752 / 753

页数：2

共 16 条

[11] FACTORS INFLUENCING OUTCOME OF PREDNISONE DOSE REDUCTION IN MYASTHENIA-GRAVIS [J].

MIANO, MA ;

BOSLEY, TM ;

HEIMANPATTERSON, TD ;

REED, J ;

SERGOTT, RC ;

SAVINO, PJ ;

SCHATZ, NJ .

NEUROLOGY, 1991, 41 (06) :919-921

[12] THE NATURAL COURSE OF MYASTHENIA-GRAVIS - A LONG-TERM FOLLOW UP STUDY [J].

OOSTERHUIS, HJGH .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1989, 52 (10) :1121-1127

[13]

Oosterhuis HJGH, 1997, MYASTHENIA GRAVIS

[14] CONTROVERSIES ABOUT THE TREATMENT OF MYASTHENIA-GRAVIS [J].

ROWLAND, LP .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1980, 43 (07) :644-659

[15] Ocular myasthenia gravis: Response to long term immunosuppressive treatment [J].

Sommer, N ;

Sigg, B ;

Melms, A ;

Weller, M ;

Schepelmann, K ;

Herzau, V ;

Dichgans, J .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 62 (02) :156-162

[16] OCULAR MYASTHENIA-GRAVIS - A CRITICAL-REVIEW OF CLINICAL AND PATHOPHYSIOLOGICAL ASPECTS [J].

SOMMER, N ;

MELMS, A ;

WELLER, M ;

DICHGANS, J .

DOCUMENTA OPHTHALMOLOGICA, 1993, 84 (04) :309-333

← 1 2 →